Selective repression of YKL‐40 by NF‐κB in glioma cell lines involves recruitment of histone deacetylase‐1 and ‐2
Krishna Bhat(WinnMed), Kenneth Aldape(National Institutes of Health)
Cited by 46
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k
Challenges to curing primary brain tumours
|Nature Reviews Clinical Oncology|2019|965
Biological Effects of Resveratrol
|Antioxidants and Redox Signaling|2001|508